BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 12, 2002
View Archived Issues
Cyclis licenses broad technology to expand ACT platform
Read More
Immunomedics' unlabeled CEA antibody inhibits tumor growth and enhances dacarbazine therapy
Read More
APT-3111 awarded E.U. orphan drug status for paroxysmal nocturnal hemoglobinuria
Read More
New modulators of adenosine receptors identified at Bayer
Read More
Japanese patent covers novel alpha2-adrenoceptor antagonists designed by Fuso scientists
Read More
Several related series of guanylate cyclase activators described by Bayer
Read More
New antitumor hydroxamates prepared and tested at Ono
Read More
Ono scientists design novel chemokine antagonists for asthma, arthritis, etc.
Read More
Tropane analogue RTI-336 as a potential therapeutic for cocaine abuse
Read More
New mu/delta opioid receptor agonist under study for the management of GI motility disorders
Read More
Beneficial effects for NCX-1000 in animal model of cholangitis
Read More
Major active component of TJ-135 determined using hepatic stellate cells
Read More
Data supporting ongoing clinical development of ACH-126443 for HBV presented at meetings
Read More
Effect of emerging precore stop codon mutation on anti-HBV activity of LY-582563/MCC-478
Read More
Antitumor activity of TRAIL-R1 MAb demonstrated in vitro and in vivo
Read More
Preclinical data reported for Ono-2506 at Neuroscience 2002
Read More
OraQuick rapid HIV-1 test approved
Read More
Inflazyme announces phase Ia and Ib results with IPL-512602
Read More
ENMD-0995 receives orphan drug designation
Read More
Aphton initiates clinical trials with G17DT for GERD in Europe
Read More
Pay now or pay later: new report sheds light on the economic impact of osteoporosis in the workplace
Read More
Inspire announces phase II results with INS-37217
Read More
Top-line results of phase III study of alvimopan in opioid bowel dysfunction
Read More
Evidence supporting the use of neurokinin receptor antagonists in depression
Read More
FDA designates Orathecin as a fast track drug
Read More
HuMax-CD4 to be tested in cancer patients
Read More
Cetirizine approved for pediatric use
Read More